Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beta Bionics (BBNX) Gross Margin (2024 - 2025)

Historic Gross Margin for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to 55.48%.

  • Beta Bionics' Gross Margin rose 21200.0% to 55.48% in Q3 2025 from the same period last year, while for Sep 2025 it was 54.51%, marking a year-over-year change of. This contributed to the annual value of 55.11% for FY2024, which is 25200.0% up from last year.
  • Per Beta Bionics' latest filing, its Gross Margin stood at 55.48% for Q3 2025, which was up 21200.0% from 53.8% recorded in Q2 2025.
  • Beta Bionics' 5-year Gross Margin high stood at 57.19% for Q4 2024, and its period low was 50.86% during Q1 2025.